BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 29, 2015
View Archived Issues
BGT-1-selective compound SBV-114 has anticonvulsant properties
Read More
Theravance Biopharma and Trek Therapeutics begin phase IIa trial of TD-6450
Read More
Quark Pharmaceutical begins patient recruitment for global pivotal study of QPI-1007
Read More
Amgen and Cytokinetics report topline results from COSMIC-HF
Read More
Kite Pharma partners with Alpine Immune Sciences to develop cancer immunotherapies
Read More
KaloBios starts phase I trial of KB-003 in patients with CMML
Read More
XBiotech to develop oral monoclonal antibody therapy for C. difficile infection
Read More
GSK's shingles vaccine containing QS-21 Stimulon shows efficacy against shingles
Read More
Ipsen and Telesta sign license agreement for MCNA in Europe and other territories
Read More
Cabaletta improves swallowing and muscle strength in phase II trial in OPMD
Read More
Absorb heart stent meets primary endpoints in ABSORB III and ABSORB China trials
Read More
Bristol-Myers Squibb updates pipeline progress of third quarter 2015
Read More
Effects of alemtuzumab in slowing brain volume loss in CARE MS I and II extension study
Read More
MVA-BN Filo enhances antibody response to Ebola vaccine candidate
Read More
LEO-43204 is effective for treating actinic keratosis on the face and chest
Read More
Drosophila cell line-derived Ebola vaccine
Read More
Sichuan Haisco Pharmaceutical divulges dual EGFR and HER2 inhibitors
Read More
U.S. and Italian team reports development of FAAH inhibitors
Read More
Almirall introduces TRPA1 antagonists
Read More
NicOx discloses NO donors
Read More
University of North Carolina reports MerTK/TYRO3 inhibitors
Read More
GSK provides update on LATITUDE-TIMI 60 trial
Read More
Gilead submits NDA for fixed-dose combination of sofosbuvir/velpatasvir for HCV
Read More
FDA approves Yervoy for adjuvant treatment of fully resected stage III melanoma
Read More
World Stroke Day: Neuroprotective microRNA, post-stroke recovery protein identified
Read More
LOXO-101 selected for NCI targeted therapy trial
Read More